Krebs Biochemicals Valuation
| KREBSBIO | 104.14 8.79 7.78% |
At this time, the firm appears to be fairly valued. Krebs Biochemicals and secures a last-minute Real Value of USD102.8 per share. The latest price of the firm is USD104.14. Our model forecasts the value of Krebs Biochemicals and from analyzing the firm fundamentals such as Operating Margin of (0.30) %, shares outstanding of 21.56 M, and Return On Asset of -0.0532 as well as examining its technical indicators and probability of bankruptcy.
Enterprise Value 4.2 B | Enterprise Value Ebitda (16.12) | Price Sales 4.268 | Enterprise Value Revenue 8.2536 |
Fairly Valued
Today
Please note that Krebs Biochemicals' price fluctuation is very steady at this time. Calculation of the real value of Krebs Biochemicals and is based on 3 months time horizon. Increasing Krebs Biochemicals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Krebs Biochemicals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Krebs Stock. However, Krebs Biochemicals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 104.14 | Real 102.8 | Hype 104.66 | Naive 122.78 |
The intrinsic value of Krebs Biochemicals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Krebs Biochemicals' stock price.
Estimating the potential upside or downside of Krebs Biochemicals and helps investors to forecast how Krebs stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Krebs Biochemicals more accurately as focusing exclusively on Krebs Biochemicals' fundamentals will not take into account other important factors: Krebs Biochemicals Cash |
|
Krebs Biochemicals Total Value Analysis
Krebs Biochemicals and is now forecasted to have takeover price of 4.18 B with market capitalization of 2.25 B, debt of 2.39 B, and cash on hands of (1 K). Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Krebs Biochemicals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.18 B | 2.25 B | 2.39 B | (1 K) |
Krebs Biochemicals Investor Information
About 78.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 10.1. Krebs Biochemicals and last dividend was issued on the 14th of September 2005. Based on the key indicators related to Krebs Biochemicals' liquidity, profitability, solvency, and operating efficiency, Krebs Biochemicals and is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Krebs Biochemicals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Krebs Biochemicals has an asset utilization ratio of 28.3 percent. This signifies that the Company is making USD0.28 for each dollar of assets. An increasing asset utilization means that Krebs Biochemicals and is more efficient with each dollar of assets it utilizes for everyday operations.Krebs Biochemicals Ownership Allocation
Krebs Biochemicals and maintains a total of 21.56 Million outstanding shares. Krebs Biochemicals and secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 77.55 % of Krebs Biochemicals and outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Krebs Biochemicals Profitability Analysis
The company reported the revenue of 504.21 M. Net Loss for the year was (197.28 M) with profit before overhead, payroll, taxes, and interest of 244.19 M.About Krebs Biochemicals Valuation
An absolute valuation paradigm, as applied to Krebs Stock, attempts to find the value of Krebs Biochemicals and based on its fundamental and basic technical indicators. By analyzing Krebs Biochemicals's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Krebs Biochemicals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Krebs Biochemicals. We calculate exposure to Krebs Biochemicals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Krebs Biochemicals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -108.7 M | -103.3 M |
Complementary Tools for Krebs Stock analysis
When running Krebs Biochemicals' price analysis, check to measure Krebs Biochemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krebs Biochemicals is operating at the current time. Most of Krebs Biochemicals' value examination focuses on studying past and present price action to predict the probability of Krebs Biochemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krebs Biochemicals' price. Additionally, you may evaluate how the addition of Krebs Biochemicals to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |